- Home
- DXLG vs VNRX Comparison
DXLG vs VNRX Comparison
Compare DXLG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- VNRX
- Stock Information
- Founded
- DXLG 1976
- VNRX N/A
- Country
- DXLG United States
- VNRX United States
- Employees
- DXLG N/A
- VNRX N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DXLG Consumer Discretionary
- VNRX Health Care
- Exchange
- DXLG Nasdaq
- VNRX Nasdaq
- Market Cap
- DXLG 64.0M
- VNRX 52.4M
- IPO Year
- DXLG 1987
- VNRX N/A
- Fundamental
- Price
- DXLG $1.15
- VNRX $0.81
- Analyst Decision
- DXLG Strong Buy
- VNRX Strong Buy
- Analyst Count
- DXLG 1
- VNRX 5
- Target Price
- DXLG $2.50
- VNRX $3.88
- AVG Volume (30 Days)
- DXLG 632.5K
- VNRX 336.8K
- Earning Date
- DXLG 05-29-2025
- VNRX 08-13-2025
- Dividend Yield
- DXLG N/A
- VNRX N/A
- EPS Growth
- DXLG N/A
- VNRX N/A
- EPS
- DXLG N/A
- VNRX N/A
- Revenue
- DXLG $457,059,000.00
- VNRX $1,308,361.00
- Revenue This Year
- DXLG N/A
- VNRX $563.72
- Revenue Next Year
- DXLG $3.56
- VNRX $160.43
- P/E Ratio
- DXLG N/A
- VNRX N/A
- Revenue Growth
- DXLG N/A
- VNRX 64.16
- 52 Week Low
- DXLG $0.90
- VNRX $0.40
- 52 Week High
- DXLG $3.93
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- DXLG 49.13
- VNRX 67.55
- Support Level
- DXLG $0.98
- VNRX $0.40
- Resistance Level
- DXLG $1.09
- VNRX $0.75
- Average True Range (ATR)
- DXLG 0.07
- VNRX 0.10
- MACD
- DXLG -0.00
- VNRX 0.02
- Stochastic Oscillator
- DXLG 36.40
- VNRX 82.00
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.